PRODUCTS

INTERNATIONAL  /  ARIPIPRAZOLE LAI «  BACK TO "INTERNATIONAL"

Aripiprazole is a partial agonist of dopamine D2 and serotonin 5HT1 receptors and antagonist of serotonin 5HT2a receptors.
It is indicated for schizophrenia in adults and in adolescents over 15.
It is also indicated for moderate to severe manic episodes in Bipolar I Disorder and for the prevention of new manic episodes.
Finally is indicated for the treatment of moderate to severe manic episodes in Bipolar I Disorder in adolescents aged over 13 years old

Under Development
Active ingredient Pharmaceutical form Package Therapeutic target
  • Aripiprazole LAI
  • Long-Acting Injectable
  • 300mg/vial
  • 400mg/vial
  • Antipsychotic

Other products in "International"